22 – 28 April 2017

Findings from the WOMAN Trial

New evidence from the WOMAN Trial suggests that the widely available and low-cost drug tranexamic acid could prevent many mothers around the world from bleeding to death from childbirth. In a BBC News article co-lead author Ian Roberts says: “Making sure the treatment is available everywhere it can save a life is hugely important. We shouldn’t have children growing up without a mother for lack of a drug that costs a dollar.”

The findings generate coverage in more than 400 outlets across the world, including The Guardian, Daily Mail, The New York Times, The Washington Post, Reuters, National Public Radio, Al Jazeera, The Hindustan Times (India), Daily Star (Bangladesh) and Nigerian Tribune.

Ian Roberts and Project Director Haleema Shakur give interviews across the BBC, including World Service Radio’s Health Check, the News Channel’s Victoria Derbyshire show (from 0h44m08s) and a live Q&A on BBC Africa Facebook page.

World Malaria Day

Our researchers speak to various outlets on the challenges and developments in tackling malaria for World Malaria Day:

The Financial Times (£) write a special report on malaria, including an article quoting Chris Drakeley on the prospect of resistance spreading to Africa: “If what we are seeing in Asia happens in Africa, the effects would be devastating. It would be a huge concern.” Corine Ngufor is also quoted in an article looking at the use of bednets (£): “Our experiments showed that effectively the nets can work. They are able to sterilise the female and reduce the next generation of mosquito.”

David Conway speaks to Newsweek about the pilot of the RTS,S malaria vaccine in Ghana, Kenya & Malawi and provides a live interview to BBC Radio Foyle (from 0h22m40s). David says: “It is a landmark step forward, the fact that the vaccine is being piloted and rolled out to see whether of it will be of use…will certainly be trailblazing for better vaccines that need to be implemented.”

Brian Greenwood provides comment to International Business Times UK on the RTS,S vaccine: “In some areas, in particular in Africa and in the Sahel, this may not be enough. We are going to need new tools, one of which will have to be a vaccine”

Ify Aniebo writes a blog for the Huffington Post on how and why African countries can be the major drivers of malaria control strategies.

Elsewhere

An analysis of drugs approved for use by the NHS Cancer Drugs Fund in England showing it was not good value for patients and society, receives wide UK coverage. The study, led by the School, was covered by outlets including BBC News, Sky News, The Times (£), Daily Mail, The Guardian, The Independent, New Scientist and via the Press Association to over 100 UK regional outlets.

In World Immunisation Week, Heidi Larson provides comment to The Independent about vaccine hesitancy and the anti-vaccination movement: “Vaccines are one of the best health inventions in history, and have saved millions of lives. They are not perfect, and they will never be perfect. But, as with all science and health interventions, you need to keep aspiring to improve what you have to make it better.”

Liam Smeeth is interviewed on BBC One’s Health: Truth or Scare (from 06m08s) discussing the benefits of statins and the media controversy surrounding the drug. Liam says: “It’s worth taking that small increased risk of diabetes because there’s huge benefits on heart attacks and strokes. Statins reduce the risk by around a quarter or a third.”

Devex interview Peter Piot for a Q&A (£) following an event at the University of Washington where he gave a talk on the future of global health. His comments also appear in another Devex article investigating innovations in science and global health: “We have much better vaccines and drugs and interventions but they’re pretty useless if they stay on the shelf.”

Comments are closed.